296 related articles for article (PubMed ID: 20043696)
1. Discovery of cyclic acylguanidines as highly potent and selective beta-site amyloid cleaving enzyme (BACE) inhibitors: Part I--inhibitor design and validation.
Zhu Z; Sun ZY; Ye Y; Voigt J; Strickland C; Smith EM; Cumming J; Wang L; Wong J; Wang YS; Wyss DF; Chen X; Kuvelkar R; Kennedy ME; Favreau L; Parker E; McKittrick BA; Stamford A; Czarniecki M; Greenlee W; Hunter JC
J Med Chem; 2010 Feb; 53(3):951-65. PubMed ID: 20043696
[TBL] [Abstract][Full Text] [Related]
2. Application of fragment-based NMR screening, X-ray crystallography, structure-based design, and focused chemical library design to identify novel microM leads for the development of nM BACE-1 (beta-site APP cleaving enzyme 1) inhibitors.
Wang YS; Strickland C; Voigt JH; Kennedy ME; Beyer BM; Senior MM; Smith EM; Nechuta TL; Madison VS; Czarniecki M; McKittrick BA; Stamford AW; Parker EM; Hunter JC; Greenlee WJ; Wyss DF
J Med Chem; 2010 Feb; 53(3):942-50. PubMed ID: 20043700
[TBL] [Abstract][Full Text] [Related]
3. Discovery and X-ray crystallographic analysis of a spiropiperidine iminohydantoin inhibitor of beta-secretase.
Barrow JC; Stauffer SR; Rittle KE; Ngo PL; Yang Z; Selnick HG; Graham SL; Munshi S; McGaughey GB; Holloway MK; Simon AJ; Price EA; Sankaranarayanan S; Colussi D; Tugusheva K; Lai MT; Espeseth AS; Xu M; Huang Q; Wolfe A; Pietrak B; Zuck P; Levorse DA; Hazuda D; Vacca JP
J Med Chem; 2008 Oct; 51(20):6259-62. PubMed ID: 18811140
[TBL] [Abstract][Full Text] [Related]
4. Combining NMR and X-ray crystallography in fragment-based drug discovery: discovery of highly potent and selective BACE-1 inhibitors.
Wyss DF; Wang YS; Eaton HL; Strickland C; Voigt JH; Zhu Z; Stamford AW
Top Curr Chem; 2012; 317():83-114. PubMed ID: 21647837
[TBL] [Abstract][Full Text] [Related]
5. Thiophene substituted acylguanidines as BACE1 inhibitors.
Fobare WF; Solvibile WR; Robichaud AJ; Malamas MS; Manas E; Turner J; Hu Y; Wagner E; Chopra R; Cowling R; Jin G; Bard J
Bioorg Med Chem Lett; 2007 Oct; 17(19):5353-6. PubMed ID: 17761418
[TBL] [Abstract][Full Text] [Related]
6. Discovery of a novel warhead against beta-secretase through fragment-based lead generation.
Geschwindner S; Olsson LL; Albert JS; Deinum J; Edwards PD; de Beer T; Folmer RH
J Med Chem; 2007 Nov; 50(24):5903-11. PubMed ID: 17985861
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of potent and selective BACE-1 inhibitors.
Björklund C; Oscarson S; Benkestock K; Borkakoti N; Jansson K; Lindberg J; Vrang L; Hallberg A; Rosenquist A; Samuelsson B
J Med Chem; 2010 Feb; 53(4):1458-64. PubMed ID: 20128595
[TBL] [Abstract][Full Text] [Related]
8. Discovery of novel non-peptide inhibitors of BACE-1 using virtual high-throughput screening.
Yi Mok N; Chadwick J; Kellett KA; Hooper NM; Johnson AP; Fishwick CW
Bioorg Med Chem Lett; 2009 Dec; 19(23):6770-4. PubMed ID: 19854048
[TBL] [Abstract][Full Text] [Related]
9. Fragment-based discovery of nonpeptidic BACE-1 inhibitors using tethering.
Yang W; Fucini RV; Fahr BT; Randal M; Lind KE; Lam MB; Lu W; Lu Y; Cary DR; Romanowski MJ; Colussi D; Pietrak B; Allison TJ; Munshi SK; Penny DM; Pham P; Sun J; Thomas AE; Wilkinson JM; Jacobs JW; McDowell RS; Ballinger MD
Biochemistry; 2009 Jun; 48(21):4488-96. PubMed ID: 19284778
[TBL] [Abstract][Full Text] [Related]
10. Application of fragment screening by X-ray crystallography to beta-secretase.
Murray CW; Callaghan O; Chessari G; Cleasby A; Congreve M; Frederickson M; Hartshorn MJ; McMenamin R; Patel S; Wallis N
J Med Chem; 2007 Mar; 50(6):1116-23. PubMed ID: 17315856
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of potent BACE-1 inhibitors incorporating a hydroxyethylene isostere as central core.
Wångsell F; Gustafsson K; Kvarnström I; Borkakoti N; Edlund M; Jansson K; Lindberg J; Hallberg A; Rosenquist A; Samuelsson B
Eur J Med Chem; 2010 Mar; 45(3):870-82. PubMed ID: 20036448
[TBL] [Abstract][Full Text] [Related]
12. Discovery of potent BACE-1 inhibitors containing a new hydroxyethylene (HE) scaffold: exploration of P1' alkoxy residues and an aminoethylene (AE) central core.
Björklund C; Adolfsson H; Jansson K; Lindberg J; Vrang L; Hallberg A; Rosenquist S; Samuelsson B
Bioorg Med Chem; 2010 Feb; 18(4):1711-23. PubMed ID: 20122837
[TBL] [Abstract][Full Text] [Related]
13. 2-Amino-3,4-dihydroquinazolines as inhibitors of BACE-1 (beta-site APP cleaving enzyme): Use of structure based design to convert a micromolar hit into a nanomolar lead.
Baxter EW; Conway KA; Kennis L; Bischoff F; Mercken MH; Winter HL; Reynolds CH; Tounge BA; Luo C; Scott MK; Huang Y; Braeken M; Pieters SM; Berthelot DJ; Masure S; Bruinzeel WD; Jordan AD; Parker MH; Boyd RE; Qu J; Alexander RS; Brenneman DE; Reitz AB
J Med Chem; 2007 Sep; 50(18):4261-4. PubMed ID: 17685503
[TBL] [Abstract][Full Text] [Related]
14. Progress toward a practical BACE-1 inhibitor.
Hills ID; Vacca JP
Curr Opin Drug Discov Devel; 2007 Jul; 10(4):383-91. PubMed ID: 17659479
[TBL] [Abstract][Full Text] [Related]
15. Acylguanidines as small-molecule beta-secretase inhibitors.
Cole DC; Manas ES; Stock JR; Condon JS; Jennings LD; Aulabaugh A; Chopra R; Cowling R; Ellingboe JW; Fan KY; Harrison BL; Hu Y; Jacobsen S; Jin G; Lin L; Lovering FE; Malamas MS; Stahl ML; Strand J; Sukhdeo MN; Svenson K; Turner MJ; Wagner E; Wu J; Zhou P; Bard J
J Med Chem; 2006 Oct; 49(21):6158-61. PubMed ID: 17034121
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and SAR of potent statine-based BACE-1 inhibitors: exploration of P1 phenoxy and benzyloxy residues.
Bäck M; Nyhlén J; Kvarnström I; Appelgren S; Borkakoti N; Jansson K; Lindberg J; Nyström S; Hallberg A; Rosenquist S; Samuelsson B
Bioorg Med Chem; 2008 Nov; 16(21):9471-86. PubMed ID: 18842420
[TBL] [Abstract][Full Text] [Related]
17. Structure based design, synthesis and SAR of cyclic hydroxyethylamine (HEA) BACE-1 inhibitors.
Rueeger H; Rondeau JM; McCarthy C; Möbitz H; Tintelnot-Blomley M; Neumann U; Desrayaud S
Bioorg Med Chem Lett; 2011 Apr; 21(7):1942-7. PubMed ID: 21388807
[TBL] [Abstract][Full Text] [Related]
18. Progress toward the discovery and development of efficacious BACE inhibitors.
Durham TB; Shepherd TA
Curr Opin Drug Discov Devel; 2006 Nov; 9(6):776-91. PubMed ID: 17117686
[TBL] [Abstract][Full Text] [Related]
19. Acyl guanidine inhibitors of β-secretase (BACE-1): optimization of a micromolar hit to a nanomolar lead via iterative solid- and solution-phase library synthesis.
Gerritz SW; Zhai W; Shi S; Zhu S; Toyn JH; Meredith JE; Iben LG; Burton CR; Albright CF; Good AC; Tebben AJ; Muckelbauer JK; Camac DM; Metzler W; Cook LS; Padmanabha R; Lentz KA; Sofia MJ; Poss MA; Macor JE; Thompson LA
J Med Chem; 2012 Nov; 55(21):9208-23. PubMed ID: 23030502
[TBL] [Abstract][Full Text] [Related]
20. Discovery and SAR of isonicotinamide BACE-1 inhibitors that bind beta-secretase in a N-terminal 10s-loop down conformation.
Stauffer SR; Stanton MG; Gregro AR; Steinbeiser MA; Shaffer JR; Nantermet PG; Barrow JC; Rittle KE; Collusi D; Espeseth AS; Lai MT; Pietrak BL; Holloway MK; McGaughey GB; Munshi SK; Hochman JH; Simon AJ; Selnick HG; Graham SL; Vacca JP
Bioorg Med Chem Lett; 2007 Mar; 17(6):1788-92. PubMed ID: 17257835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
